GB1225979A - - Google Patents
Info
- Publication number
- GB1225979A GB1225979A GB1225979DA GB1225979A GB 1225979 A GB1225979 A GB 1225979A GB 1225979D A GB1225979D A GB 1225979DA GB 1225979 A GB1225979 A GB 1225979A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vitamin
- march
- injectable
- water
- propionate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1,225,979. Injectable vitamin compositions. EASTMAN KODAK CO. 22 March, 1968 [23 March, 1967], No. 13956/68. Heading A5B. An injectable, essentially non-aqueous (less than 10% water) vitamin composition comprises at least one of: vitamin A-propionate, -butyrate or -valerate and an oil-and water-soluble polyoxyethylene condensate at a concentration of at least 25% by weight of the vitamin component or components. Suitable condensates are polyoxyethylene sorbitan fatty acid esters and polyoxyethylated vegetable oils. The vitamin composition may also comprise one or more of vitamin A acetate, vitamin D and vitamin E. A viscosity-reducing organic ester, e.g. ethyl lactate, ethyl propionate or diethyl carbonate may also be present.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62546767A | 1967-03-23 | 1967-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1225979A true GB1225979A (en) | 1971-03-24 |
Family
ID=24506219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1225979D Expired GB1225979A (en) | 1967-03-23 | 1968-03-22 |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1225979A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0045655A2 (en) * | 1980-08-04 | 1982-02-10 | Merck & Co. Inc. | Solubilization of ivermectin in water |
GB2145331A (en) * | 1983-05-02 | 1985-03-27 | Scherer R P Pty Ltd | Vitamin compositions |
EP0194880A2 (en) * | 1985-03-12 | 1986-09-17 | Sankyo Company Limited | Multivitamin preparation |
FR2598320A1 (en) * | 1985-12-24 | 1987-11-13 | Seuref Ag | WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS |
EP2832349A4 (en) * | 2012-03-31 | 2015-09-02 | Lipont Pharmaceuticals Inc | Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof |
EP2849723B1 (en) | 2012-05-18 | 2018-05-02 | Genentech, Inc. | High-concentration monoclonal antibody formulations |
CN109498607A (en) * | 2018-12-04 | 2019-03-22 | 宁夏智弘生物科技有限公司 | A kind of vitaminAD E injection for animals and preparation method |
US12018091B2 (en) | 2020-10-28 | 2024-06-25 | Genentech, Inc. | High-concentration monoclonal antibody formulations |
-
1968
- 1968-03-22 GB GB1225979D patent/GB1225979A/en not_active Expired
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0045655A2 (en) * | 1980-08-04 | 1982-02-10 | Merck & Co. Inc. | Solubilization of ivermectin in water |
EP0045655A3 (en) * | 1980-08-04 | 1982-10-06 | Merck & Co. Inc. | Solubilization of ivermectin in water |
GB2145331A (en) * | 1983-05-02 | 1985-03-27 | Scherer R P Pty Ltd | Vitamin compositions |
EP0194880A2 (en) * | 1985-03-12 | 1986-09-17 | Sankyo Company Limited | Multivitamin preparation |
EP0194880A3 (en) * | 1985-03-12 | 1987-09-02 | Sankyo Company Limited | Multivitamin preparation |
FR2598320A1 (en) * | 1985-12-24 | 1987-11-13 | Seuref Ag | WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS |
EP2832349A4 (en) * | 2012-03-31 | 2015-09-02 | Lipont Pharmaceuticals Inc | Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof |
US10568890B2 (en) | 2012-03-31 | 2020-02-25 | Xi'an Libang Pharmaceutical Co., Ltd | Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof |
EP2849723B1 (en) | 2012-05-18 | 2018-05-02 | Genentech, Inc. | High-concentration monoclonal antibody formulations |
CN109498607A (en) * | 2018-12-04 | 2019-03-22 | 宁夏智弘生物科技有限公司 | A kind of vitaminAD E injection for animals and preparation method |
US12018091B2 (en) | 2020-10-28 | 2024-06-25 | Genentech, Inc. | High-concentration monoclonal antibody formulations |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO940276L (en) | Triglyceridpreparater | |
GB1193027A (en) | Antioxidant Compositions | |
GB1225979A (en) | ||
JPS5221006A (en) | Oil and fat composition | |
GB535219A (en) | Improvements in and relating to polymerizable compositions | |
JPS5342533A (en) | Interlock unit for memory content alteration | |
JPS5215549A (en) | Stabilized polyurethane compositions | |
JPS5212256A (en) | Halogen-containing resin compositions | |
JPS5664772A (en) | Storage of food | |
CA931502A (en) | Method for the stabilization of phosphoric acid ester pesticides and compositions stabilized by such esters | |
JPS5483910A (en) | Production of fats and oils for foods | |
JPS53137255A (en) | Organic cellulose ester resin composition | |
JPS5334719A (en) | Preparation of substituted or unsubstituted alpha-oxysuccinic acid esters | |
JPS5222450A (en) | Data processor | |
JPS5269950A (en) | Polyolefin compositions with improved now-fogging and antistatic prope rties | |
JPS51151789A (en) | Process for the manufacture of film- forming aqueous emulsion | |
JPS5453111A (en) | Preparation of oil for roasting on hot plate | |
JPS545948A (en) | Cyclopropanecarboxylic acid esters, process for their prparation, and isecticide having low toxicity to fishees, containing the same as active constituents | |
JPS5460303A (en) | Antioxidant for fat and oil and method of preventing oxidation | |
JPS5351209A (en) | Additives for mixtures of pulverized coals and oils | |
JPS52113413A (en) | Gas turbine control means | |
JPS5263874A (en) | Waterdrop emulsion in oil | |
JPS539701A (en) | Preparation of epoxy compounds | |
JPS5583708A (en) | Non-flammable cellulosic nail lacquer | |
JPS5257114A (en) | Process for ether-containing acrylic acid ester or methacrylic acid es ter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |